共 50 条
- [24] Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer LANCET ONCOLOGY, 2021, 22 (09): : E380 - E380
- [25] Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer Current Oncology Reports, 2023, 25 : 83 - 91
- [28] Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer Current Urology Reports, 2013, 14 : 90 - 93
- [30] Long-term Outcomes from Re-resection for High-risk Non-muscle-invasive Bladder Cancer: A Potential to Rationalize Use EUROPEAN UROLOGY FOCUS, 2019, 5 (04): : 650 - 657